![EXINI launching a ne](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINI launching a new website about the imaging biomarker Bone Scan Index
December 18, 2013 08:27 ET
|
EXINI Diagnostics AB
Lund, Sweden, 2013-12-18 14:27 CET (GLOBE NEWSWIRE) --
Bone Scan Index (BSI) has attracted great interest by offering new possibilities within cancer care. A new website...
![EXINI lanserar en ny](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINI lanserar en ny webbsida om imaging biomarkören Bone Scan Index
December 18, 2013 08:27 ET
|
EXINI Diagnostics AB
Lund, Sverige, 2013-12-18 14:27 CET (GLOBE NEWSWIRE) --
Bone Scan Index (BSI) har väckt stort intresse genom att erbjuda nya möjligheter inom cancervården. Nu lanseras en ny webbsida...
![EXINI: Success for B](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINI: Success for BSI at large congress on urological cancer
November 25, 2013 08:09 ET
|
EXINI Diagnostics AB
Lund, Sweden, 2013-11-25 14:09 CET (GLOBE NEWSWIRE) --
EXINI's new website bonescanindex.org created considerable interest at EMUC (European Multidisciplinary Meeting on Urological Cancer)...
![EXINI: Framgång för](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINI: Framgång för BSI vid stor kongress om urologisk cancer
November 25, 2013 08:09 ET
|
EXINI Diagnostics AB
Lund, Sverige, 2013-11-25 14:09 CET (GLOBE NEWSWIRE) --
EXINI:s nya webbplats bonescanindex.org rönte stort intresse vid EMUC (European Multidisciplinary Meeting on Urological Cancer) i...
![EXINI: Bonenavi 2.0](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINI: Bonenavi 2.0 is now officially released
November 22, 2013 02:45 ET
|
EXINI Diagnostics AB
Lund, Sweden, 2013-11-22 08:45 CET (GLOBE NEWSWIRE) --
FUJIFILM RI Pharma Co., Ltd. officially released the updated version Bonenavi 2.0, all according to plan. Bonenavi is the Japanese...
![EXINI: Bonenavi 2.0](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINI: Bonenavi 2.0 är nu officiellt lanserad
November 22, 2013 02:45 ET
|
EXINI Diagnostics AB
Lund, Sverige, 2013-11-22 08:45 CET (GLOBE NEWSWIRE) --
FUJIFILM RI Pharma Co., Ltd har släppt, helt enligt plan, en uppdaterad version av Bonenavi 2.0 på marknaden. Bonenavi är den...
![EXINI: Delårsrapport](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINI: Delårsrapport januari - september 2013
November 12, 2013 02:55 ET
|
EXINI Diagnostics AB
Lund, Sverige, 2013-11-12 08:55 CET (GLOBE NEWSWIRE) --
VIKTIGA AVTAL TECKNADE
Tredje kvartalet
Nettoomsättningen uppgick till 1 681 (1 427) TSEK
Resultatet efter finansiella...
![EXINIs satsning inom](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINIs satsning inom imaging biomarkörer rönte stort intresse vid EANM (European Association of Nuclear Medicine)
October 30, 2013 04:29 ET
|
EXINI Diagnostics AB
Lund, Sverige, 2013-10-30 09:29 CET (GLOBE NEWSWIRE) --
EXINI deltog på EANM (European Association of Nuclear Medicine) i Lyon 19-23 oktober. Där lanserades en uppdaterad version av EXINI...
![EXINIs investment in](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINIs investment in imaging biomarkers attracted considerable interest at EANM (European Association of Nuclear Medicine)
October 30, 2013 04:29 ET
|
EXINI Diagnostics AB
Lund, Sweden, 2013-10-30 09:29 CET (GLOBE NEWSWIRE) --
EXINI attended the EANM (European Association of Nuclear Medicine) in Lyon October 19 to 23. At the congress, an updated version of...
![EXINI ingår avtal me](/news-release/logo/242048/0/242048.png?lastModified=12%2F09%2F2016%2023%3A36%3A52&size=2)
EXINI ingår avtal med läkemedelsbolag
October 03, 2013 02:30 ET
|
EXINI Diagnostics AB
Lund, Sverige, 2013-10-03 08:30 CEST (GLOBE NEWSWIRE) --
EXINI Diagnostics ingår ett nytt samarbete med läkemedelsbolag för att kliniskt utvärdera en cancerbehandling. Avtalet påvisar den...